Arunjyoti Bio Ventures reported a net loss of ₹4.54 crore for FY26, a significant increase from ₹0.28 crore loss last year. The company is also seeking shareholder approval for a name change to Pasura Industries Limited.
Arunjyoti Bio Ventures Reports Wider Net Loss, Proposes Name Change
Arunjyoti Bio Ventures posted a net loss of ₹4.54 crore in FY 2025-26, a significant increase from ₹0.28 crore in the previous fiscal year. The company's total income also saw a marginal dip to ₹27.87 crore.
Reader Takeaway: Widening losses and operational challenges overshadow capacity expansion and brand unification efforts.
What just happened
Arunjyoti Bio Ventures Ltd. reported a net loss of ₹4.54 crore for the fiscal year 2025-26. This marks a substantial deterioration from the ₹0.28 crore loss recorded in FY 2024-25. Total income declined slightly to ₹27.87 crore from ₹28.17 crore in the prior year. Management cited increased manufacturing and operational costs, including raw materials and utilities, coupled with the under-utilization of manufacturing capacity and higher employee expenses as reasons for the loss.
Why this matters
The widening net loss and operational cost pressures are a significant concern for shareholders. While the company is expanding its production capacity, the financial performance indicates underlying challenges in managing costs and profitability. The proposed name change to "Pasura Industries Limited" signals a strategic shift towards group brand uniformity, but its success hinges on resolving current operational and financial headwinds.
The backstory
Arunjyoti Bio Ventures has been navigating a complex operational landscape. In FY 2025-26, the company commissioned a new Jelly Pouch Production Line at its Jangaon facility to boost capacity. However, this expansion comes amidst significant cost escalations and a substantial increase in net losses. The company also faces scrutiny over related party transactions and executive remuneration.
What changes now
Shareholders will vote on several key proposals: a name change to "Pasura Industries Limited", ratification of an ₹0.81 crore loan to Pasura Xpress LLP, and waivers for excess managerial remuneration paid to two directors for FY 2025-26. The board has also approved increased remuneration packages for three whole-time directors effective April 1, 2026. These decisions will shape the company's governance and financial structure moving forward.
Risks to watch
Several risks have been highlighted by auditors and management. These include several 1-day delays in interest and principal repayments on a term loan with Axis Bank during FY 2025-26. Delays in paying statutory dues like TDS and provident fund were attributed to KYC and operational issues. Furthermore, revenue concentration with Tata Consumer Products Limited (TCPL) as a major customer presents a significant dependency risk.
Peer comparison
(No peer comparison data available in the filing.)
Context metrics (time-bound)
- Net Profit/(Loss) FY 2025-26: ₹(4.54) crore
- Net Profit/(Loss) FY 2024-25: ₹(0.28) crore
- Total Income FY 2025-26: ₹27.87 crore
- Total Income FY 2024-25: ₹28.17 crore
- Total Assets FY 2025-26: ₹54.16 crore
- Total Assets FY 2024-25: ₹61.39 crore
- Loan to Pasura Xpress LLP: ₹0.81 crore
- Excess Managerial Remuneration (Mr. Murthy): ₹9.71 lakh
- Excess Managerial Remuneration (Mr. Vishal): ₹15.48 lakh
What to track next
Investors should monitor the outcome of the shareholder votes on the name change and related party transactions. The company's ability to manage operational costs, improve capacity utilization, and resolve compliance issues will be crucial. The sustainability of its relationship with major customer TCPL also remains a key point to track.